When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance or the ability to use the same packaging in multiple countries, poorly informed decisions concerning primary packaging can have a significant impact on your clinical supply strategy, potentially for the duration of your study.
Catalent’s packaging expert Steve McMahon’s thoughts on best practices and important considerations when deciding upon your primary packaging strategy.
